GC
ALNA

Grimes & Company’s Allena Pharmaceuticals ALNA Stock Holding History

Grimes & Company’s Portfolio ALNA Stock Details ALNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-10,000
Closed -$13K – 294
2020
Q4 		$13K Sell
10,000
-1,289
-11% -$1.8K ﹤0.01% 266
2020
Q3 		$17K Buy
+11,289
New +$15.9K ﹤0.01% 249

Other funds holding ALNA

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
TGI
TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Grimes & Company's ALNA Position: Q1 2021 in Review

Grimes & Company sold out of Allena Pharmaceuticals (ALNA) in Q1 2021, closing a stake of 10,000 shares — an estimated $13K sold.

Grimes & Company first reported a position in ALNA in Q3 2020 and held it in 2 quarters. The position peaked at $17K in Q3 2020. 30 funds tracked by Wall St. Rank hold ALNA as of Q1 2021.

  • Grimes & Company reported no remaining Allena Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Grimes & Company sold 10,000 Allena Pharmaceuticals shares in Q1 2021, an estimated $13K.
  • Grimes & Company first reported a position in Allena Pharmaceuticals in Q3 2020 and held it in 2 quarters.
  • Grimes & Company's Allena Pharmaceuticals position peaked at $17K in Q3 2020.
  • 30 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q1 2021.

Based on Grimes & Company's 13F filing for Q1 2021, filed 12 May 2021.